Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News EuroPCR 2025

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Yael L. Maxwell

May 30, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Conference News EuroPCR 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

Caitlin E. Cox

May 17, 2023

Presentation EuroPCR 2023

The European Bifurcation Club Left Main Coronary Stent study - a randomised comparison of stepwise provisional versus systematic dual stenting strategies (EBC MAIN): 3 year results

Presenter: David Hildick-Smith

May 16, 2023

News Conference News EuroPCR 2023

Flushing TAVI Valves With Carbon Dioxide May Protect Against Brain Injury

Todd Neale

May 16, 2023

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News EuroPCR 2022

Robotic PCI Safe, Feasible in Noncomplex Cases: R-Evolution

Yael L. Maxwell

May 18, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News EuroPCR 2021

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

Michael O'Riordan

May 21, 2021

Advertisement

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

IVL Effective in Severely Calcified Lesions, Especially in Women

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

The European Bifurcation Club Left Main Coronary Stent study - a randomised comparison of stepwise provisional versus systematic dual stenting strategies (EBC MAIN): 3 year results

Flushing TAVI Valves With Carbon Dioxide May Protect Against Brain Injury

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Robotic PCI Safe, Feasible in Noncomplex Cases: R-Evolution

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content